Aims: Aldehyde dehydrogenase 2 (ALDH2) protects cells from ethanol toxicity by metabolizing acetaldehyde. We studied the single nucleotide polymorphism (SNP) rs886205s located between a negative and a positive regulating promoter element in the ALDH2 gene. The negative regulatory region was already associated with differential DNA methylation in the two allele variations of rs886205 SNP. Another CpG island, in the positive regulatory region of the ALDH2 promoter, extends through the SNP rs886205 and a nuclear receptor response element. Methods: We assessed rs886305 genotype and DNA methylation using bisulfite sequencing in a cohort of 83 male alcohol-dependent patients undergoing detoxification treatment (Days 1, 7 and 14) and in 33 male age-matched controls. Luciferase reporter assays were performed to address the functional significance of genotype and methylation. Results: We observed a higher methylation in alcohol-dependent patients compared to controls. Patients with AA (n = 52) or GG/GA (n = 31) genotype differed significantly in baseline methylation levels as well as in methylation kinetics during withdrawal. AA carriers display an increase in methylation from low baseline levels while GG/GA showed the inverse pattern. The reporter gene assays corroborate these data by showing a significant effect of genotype on ALDH2 expression as well as an interaction between genotype and methylation. Conclusion: Our results describe a new regulatory role of rs886205 in the methylation of ALDH2 promoter region and provide additional insight into the complex regulation of ALDH2 under the condition of alcohol dependence. Short summary: Genetic variations have been described to influence DNA promoter methylation of various genes. We investigated the association between the polymorphism rs886205, located on ALDH2 promoter and methylation kinetics of the neighboring CpG island in alcohol-dependent patients. Luciferase reporter assays showed functional significance of genotype, methylation and a genotype-epigenotype interaction in vitro.
INTRODUCTION
Excessive alcohol intake has been shown to harm the body in countless ways. Even though ethanol has a direct effect on the cell membrane and proteins, acetaldehyde, a byproduct of ethanol metabolism has been proven to be more reactive and damaging. Acetaldehyde can bind to enzymes and other proteins as well as DNA to generate harmful adducts to act as a carcinogen. It is important to a wide array of processes as diverse as craving to cellular functions, which regulate enhanced reactive oxygen species production (Zakhari, 2006) . Aldehyde dehydrogenase 2 (ALDH2) is the key enzyme for metabolizing acetaldehyde derived from ethanol in liver cells. It is expressed in mitochondria, at high levels in liver and kidney and comparatively low levels in skeletal and cardiac muscles (Stewart et al., 1996b) . Understanding the factors that modulate ALDH2 levels is important as they play a major role in the elimination kinetics of alcohol and therefore the resultant toxicity it exerts on various organs.
Genetic variations are one of the prime determinants of multifactorial physiological and psychological disorders that are linked to environmental influences (Tsuang et al., 2004; Caspi and Moffitt, 2006) . Single nucleotide polymorphisms (SNPs) are a well-studied domain in alcohol addiction mainly as they are responsible for inter-ethnic and inter-individual differences in the pathology of the disorder (Quertemont, 2004) . Various SNPs have been discovered in the family of alcohol dehydrogenases, microsomal enzyme CYP2E1 and in several other alcohol metabolizing enzymes including ALDH2 (Yoshida et al., 1991; Yoshida, 1992) . The most researched of the ALDH2 SNP is rs671, which leads to an inactive enzyme, resulting in the accumulation of acetaldehyde (Yoshida et al., 1984; Crabb et al., 1989) . Rs671 is restricted to the East Asian population and does not explain the addiction or the adverse effects of alcohol consumption in the African, American and European populations. In the quest to find new markers, SNP rs886205 (−361 A/G, from ATG of the gene) was identified in a cohort of African-American and Caucasian individuals (Chou et al., 1999) . Rs886205 is of interest for the present study as it is a commonly occurring polymorphism in German population with genotype frequencies around 68% for AA, 28% for A/G and 3% for GG (Haschemi Nassab et al., 2015) . Moreover, it has repeatedly been associated with upper digestive tract cancers upon medium to heavy alcohol consumption (Hashibe et al., 2006; Bye et al., 2011) . ALDH2 promoter has been characterized over the past two decades providing insight on expression and regulation in response to various external and internal cues. The basal expression of ALDH2 is mediated by nuclear factor-Y/CCAAT protein transcription factors binding to a CCAAT box. Various reporter assays established that a fragment from −160 base pairs (bp) to −490 bp represents a positive regulatory element. Subsequently, the deletion of upstream sequences from −490 to −600 bp (Stewart et al., 1996a) and −744 to −981 bp (Kimura et al., 2009 ) resulted in increased transcriptional activity, thereby indicating the presence of a negative regulatory fragment. The region between −307 and −363 bp from translation start site has been identified as a nuclear receptor response element (NRRE) and is shown to bind various transcription factors from nuclear receptor superfamily including activators like hepatocyte nuclear factor-4 (Stewart et al., 1998) and retinoid X receptor alpha (RXRα) as a homodimer or heterodimerized with retinoic acid receptor alpha or gamma (RARα/γ) (Pinaire et al., 2003) as well as repressors such as chicken ovalbumin upstream promoter-transcription factor (Coup -TFI) and apolipoprotein regulatory protein-1 (Pinaire et al., 2000) . These findings highlight a complex and crucial region of ALDH2 promoter that seems to be regulated by a plethora of non-steroid nuclear receptors (Fig. 1a) .
In the past decade, epigenetics has emerged to be a pivotal mechanism through which alcohol and other drugs leave a mark on gene regulation (Shukla et al., 2008) . Alcohol has been previously shown to modulate the DNA methylation machinery (Bonsch et al., 2006) as well as the metabolites (Bonsch et al., 2004) . Genome-wide DNA methylation analysis has shown a clear influence of alcohol addiction on epigenetic regulation of various genes including a member of aldehyde dehydrogenase family ALDH3B2 (Zhang et al., 2013) .
While the negative regulatory region in ALDH2 (−744 to −981 bp) promoter differentially suppresses the activity of −360 G and −360 A allele and G allele carriers (Kimura et al., 2009) , there has been no further investigation on how rs886205 interacts with functional elements of the ALDH2 promoter.
Our aim is to study the interaction of genetic and epigenetic elements of ALDH2 regulation during alcohol intoxication. We have previously shown that alcohol-dependent patients show a significant increase in methylation of CpGs located in the negative regulatory region. Kinetics of demethylation of these CpGs after 7 days of detoxification was different in rs886205 A allele homozygous compared to G allele homozygous and heterozygous patients (Haschemi Nassab et al., 2016) .
Given the distinctive effect of rs886205 on the methylation of an upstream negative regulatory region, it seems to function through the complex mechanism for the basal state as well as ethanolmediated regulation of ALDH2 gene. In this study, we analyzed the methylation in the CpGs positioned within the NRRE to investigate the potential functional proximity to rs886205 and the resulting effect on ALDH2 expression.
MATERIALS AND METHODS

Patients and controls
A cohort study was performed with 96 alcohol-dependent male patients [age: 43.15 years (SD: 8.24), AA = 52 and GG/GA = 33] and a control cohort consisting of 33 males [age: 44.06 years (SD: 11.46); AA = 16 and GG/GA = 17]. Sociodemographic data for both patients and controls are shown in Supplementary Table 1. All patients fulfilled the criteria for alcohol dependence defined by the International Classification of Diseases-10 and Diagnostic and Statistical Manual of Mental Disorders-IV and were admitted for detoxification treatment in the Hospital for Psychiatry, Psychotherapy and Psychosomatics, Obermain, Germany. Patients received detailed physical examination and urine testing for drug screening. Fasting blood was collected on Days 1, 7 and 14 of the admission in ethylenediaminetetraacetic acid vials and was stored at −80°C. Serum was obtained by centrifuging a vial of clotted blood at 1400 × g for 10 min at 4°C and after that aliquoted and stored at −80°C. The absence of alcohol dependence in the control cohort was tested using the Alcohol Use Disorder Identification Test (AUDIT) score. Patients and controls have been described in detail previously (Wilhelm et al., 2011) . For gender-related analysis, 37 females [age: 42.24 years (SD: 9.51), AA = 21 and GG/GA = 16] were included.
Genotyping
Both patients and controls were genotyped for SNP rs886205 as previously described (Haschemi Nassab et al., 2015) and were grouped into two groups: A-Allele (A/A) and G-Allele (G/G and A/G). Genotyping was carried out for 83 patients of the main collective.
Testosterone ELISA
The testosterone serum levels were assessed using enzyme-linked immunosorbent assay (ELISA) (KGE010, R&D Systems, WiesbadenNordenstadt, Germany). The assay was performed according to the manufacturer's directions. The lower threshold of determination was 0.041 ng/ml. The assay range was 0-10 ng/ml. The interassay coefficients of variation were 5.0% and 8.7%.
Bisulfite sequencing
Genomic DNA was extracted by automated magnetic-bead based isolation of genomic DNA from whole blood (Macherey Nagel, NucleoMag ® Blood 200 µL, Düren, Germany). Concentration and purity of isolated genomic DNA were determined using Nanodrop (VWR, Radnor, USA). A total amount of 500 ng was set up for bisulfite conversion by using EpiTect Bisulfite Kit (Qiagen, Hilden, Germany) according to the kit protocol. Target region was PCR amplified and sequenced using Genetic Analyzer 3500xL (ABI Life Technologies, Grand Island, NY, USA). More information can be found in Supplementary Text 1.1.
Luciferase assays
ALDH2 promoter fragments were cloned in a CpG-free luciferase vector pCpGL (Klug and Rehli, 2014) . The K562 cells cultured in 96-well plates were transfected with the promoter constructs (methylated/unmethylated) and were harvested for luciferase assay after 24 h. Additional information about cloning and transfection is given in Supplementary Text 1.2. For alcohol incubation experiments, 96-well plates were kept inside of PVC chambers filled with 200 ml of water and either 0.05%, 0.1%, 0.25%, 0.5% or 1% (10.85, 21.70, 54.26, 108 .53 or 217.07 mM, respectively) of alcohol on metal plates (Haschemi Nassab et al., 2012), 6 h after transfection. Cells were harvested after 24 and 48 h for luciferase assay.
The assay was performed using Dual Luciferase Reporter Assay System (Promega, Madison, WI, USA) on GloMax-Multi Detection System (Promega). The assay was done in triplicates and was repeated three times. For analysis, firefly readings were normalized by respective renilla luminescence readings and normalized values were imported to Graph Pad Prism 5 (Graph Pad, Inc., La Jolla, CA, USA).
Statistical analysis
The methylation of each of the 32 CpGs in the CpG island was assessed using the Epigenetic Sequencing Methylation Analysis Software (ESME) (Lewin et al., 2004) , which compares each methylation site to the original sequence of the promoter. Only 31 CpG sites yielding valid results in >90% of all samples were used for further analyses.
For methylation analysis, mixed linear models for repeated measurements were performed including the factors: genotype and alcohol withdrawal time point (Days 1, 7 and 14) as they are expected to have an impact on the mean methylation levels ALDH2 promoters. Furthermore, we performed hierarchical cluster analysis using between group linkage with squared Euclidean distance and found a two-cluster-solution ( Supplementary Fig. 1 ). Luciferase data were analyzed using two-way ANOVA to assess the effect of genotype and methylation on ALDH2 luciferase activity. In the case of alcohol incubation experiments, mixed linear models were used to study the interaction between factors like ethanol concentration, methylation, genotype and time point. P values of <0.05 were considered to indicate statistical significance. Data were analyzed employing IBM SPSS Statistics for Windows, Version 23 (IBM Corp., Armonk, NY, USA) and illustrated using Graph Pad Prism 5 (Graph Pad, Inc.).
RESULTS
Methylation analysis
We analyzed DNA methylation of the ALDH2 promoter region to understand the effect of rs886205 genotype on the alcohol-mediated regulation of ALDH2 (Fig. 1a) . Visual inspection of methylation rates over the whole fragment indicated the presence of various CpG clusters and hierarchical cluster analysis confirmed the presence of two clusters. Cluster 1 included CpG −418, −407, −393, −389, −349 and −339 and cluster 2 covered CpG −437, −339 and rest of the 23 CpGs from CpG −288 to CpG −144 ( Supplementary  Fig. 1 ). We excluded cluster 2 due to methylation rates below the sensitivity of Sanger sequencing and variance below 0.001. Therefore, all following results were calculated only for cluster 1.
Effect of alcohol addiction on ALDH2 promoter methylation
To analyze group (patients and controls) differences, we used a linear mixed model computing methylation as a dependent variable and CpG, group, CpG × group interaction as well as smoking, BMI and age as covariates. We found significant effects of individual CpG position (F (5, 740) = 4.155; P = 0.001) and group (F (1, 740) = 8.763, P = 0.003; Fig. 1b) . No CpG × group interaction occurred (F (5, 740) = 0.533, P = 0.751). We found independent effects of age (estimate: 0.0012; SE: 0.0003; F (1, 740) = 13.898, P < 0.0001) and BMI (estimate: −0.0015; SE: 0.0007;
To analyze the effect of alcohol withdrawal in patients, we used a linear mixed model computing methylation as dependent variable and CpG, time point and smoking, BMI and age as predictors. Though we did not find a significant change over different time points (F (2, 1444) = 0.528, P = 0.590) (Fig. 1c) , we observed a significant effect of CpG position (F (5, 1444) = 13.733, P < 0.0001). No effect of smoking, age or BMI was observed.
Effect of rs886205 on ALDH2 promoter methylation To study the effect of rs886205 on ALDH2 promoter methylation during alcohol consumption, we used baseline methylation of patients and controls in a linear mixed model with allele and group as factors along with smoking, age and BMI as confounding factors. No overall effect of allele was observed. Group remained a significant factor (F (1, 655) = 11.437, P = 0.001) that is the differences in methylation between patients and controls are independent of the allele. No group × allele or CpG × allele interaction was seen. However, when we analyzed data for patients and controls separately, we observed a significant effect of allele only in the patients (F (1, 482) = 5.983, P = 0.015). No independent effect of smoking, age and BMI or CpG × allele interaction was found.
To further assess the effect of the allele on methylation during withdrawal, we used a linear mixed model with methylation as the dependent variable and CpG, smoking, allele, time point and allele × time point as factors along with age and BMI as covariates. An overall highly significant effect of allele (F (1, 1444) = 14.9, P < 0.0001) and allele × time point interaction (F (2, 1444) = 19.604, P < 0.0001) (Fig. 1d ) was seen. No independent effect of smoking, age and BMI was found. Effect of allele was more significant on Day 7 (F (1, 467) = 19.740, P < 0.0001) and Day 14 (F (1, 470) = 20.301, P < 0001) of withdrawal compared to Day 1 (F (1, 482) = 5.983, P = 0.015). Furthermore, when analyzing the effect of time point within the groups of patients with AA or with GG/GA allele separately, we found a significant effect of time point on methylation in both groups (AA: F (2, 896) = 12.149, P < 0001; GG/GA: F (2, 524) = 8.571, P > 0001). Also, both allele types showed significant differences in methylation between Days 1 and 7 (AA, P < 0.0001; GG, P = 0.001), and Days 1 and 14 (AA, P = 0.002; GG, P = 0.001) (Fig. 1d) .
Gender-dependent effects of rs886205 on ALDH2 promoter methylation of controls Although patients were compared to only the 33 male participants, we analyzed methylation of target region additionally in an independent cohort of female controls to assess gender-based differences. The linear mixed model was employed with methylation as the dependent variable and gender and allele as predictors. We observed a significant effect of gender (F (1, 397) = 11.219, P = 0.001) and allele (F (1, 397) = 5.684, P = 0.018). Further analysis showed that allele-dependent differences in methylation were only significant in females (P < 0.05) (Fig. 2) .
Allele-dependent effects of testosterone on ALDH2 methylation Ethanol has been shown to increase estrogen levels by increasing hepatic aromatase enzyme activity and thus converting testosterone to estrogen in male patients (Gordon et al., 1979) . To test for possible effects of steroid hormones on ALDH2 methylation in alcoholdependent patients, we analyzed the association of testosterone levels with methylation at different time points.
We found a significant negative association between testosterone levels and methylation on Day 1. Further analysis showed that mainly AA homozygous patients are accountable for this effect. During detoxification, this association changes in a way that we found significant positive association between testosterone and methylation for AA homozygous carriers, while GG/GA carriers had a significant negative association. At the end of treatment, no significant association was observable (Table 1) .
Luciferase assays
Effect of methylation and rs886205 on ALDH2 promoter activity The positive regulatory fragment (F1_A/G) and the putative fulllength promoter (F6_A/G) were cloned in a CpG-free luciferase vector to study the functional significance of methylation. The G allele containing, pCpGL-F1_G construct shows higher transcription than pCpGL-F1_A (F (1, 16) = 6.43, P = 0.022). On the contrary, pCpGL-F6_A shows higher transcriptional activity than pCpGL-F6_G (F (1, 16) = 12.91, P = 0.0024) (Fig. 3) . Methylation of plasmids reduced the activity in both pCpGL-F1 and pCpGL-F6 constructs (P < 0.0001). Interestingly, the interaction between methylation and genotype could only be observed in F6 (F (1, 16) = 5.45, P = 0.033). This could be due to contribution of the negative regulatory region in the complete fragment F6 (Fig. 3) . F3 was cloned as a control without the previously reported basal promoter region (−70 to −120 bp), leading to a significant reduction in promoter activity (P > 0.0001).
Effect of alcohol and rs886205 on ALDH2 promoter activity To assess the effect of alcohol on rs886205 mediated regulation in vitro, we used K562 cell line and an incubation system that simulates alcohol intoxication (see 'Materials and Methods' section). We observed a 6-8-fold increase in transcriptional activity upon incubation with 1% alcohol. No effect of genotype was found in cells incubated with ethanol in any of the fragments (Supplementary Fig. 3 ). As 1% ethanol is much higher than the physiological concentration of alcohol during intoxication in patients, we chose four concentrations (0.05%, 0.1%, 0.25% and 0.5%) of ethanol to investigate whether the rs886205 dependent regulation of ALDH2 promoter can be observed in a particular concentration of ethanol. Positive regulatory fragment (pCpGL-F1) and full promoter (pCpGL-F6) were used for this experiment (Fig. 4) .
We did not observe any effect of genotype upon alcohol incubation on luciferase activity of neither F1 nor F6 promoter fragments. As expected, methylation had a significant effect on the transcriptional activity of F1 and F6 after 24 h as well as after 48 h of incubation (P < 0.0001). Furthermore, ethanol incubation changed promoter activity of both the fragments (P < 0.0001).
Even though no effect of genotype was observed, an interaction between genotype and methylation in both the fragments after 48 h of incubation was seen [F1: (F (1, 158) = 9.179, P = 0.003) and F6: (F (1, 158) = 7.551, P = 0.007)]. Another interesting interaction observed was between ethanol and methylation in both fragment 1 [24 h: (F (4, 158) = 3.538, P = 0.009) and 48 h: (F (4, 158) = 5.199, P = 0.001)] and fragment 6 [24 h: (F (4, 158) = 6.646, P = 0.000) and 48 h (F (4, 158) = 2.429, P = 0.05)] (Fig. 4) .
DISCUSSION
The central role of ALDH2, being the only acetaldehyde eliminator in ethanol metabolism, makes the investigation of its complex regulation essential for addiction research. Effect of SNP rs886205 on methylation of a CpG island present in a regulatory region of ALDH2 was investigated in a cohort of alcohol-dependent patients during withdrawal. Using a hypothesis-free algorithm, we split the Association between cluster 1 CpG methylation and testosterone serum levels. Statistical data are derived from mixed linear models for the whole sample and AA and GA/GG allele carriers separately. Parameter estimates are provided with standard errors (SE) and F and P values. A/A, individual with two A alleles; A/G, individual with one G allele; G/G, individual with two G alleles. Fig. 2 . Methylation of analyzed cluster 1 CpGs is higher in females with AA genotype in comparison to males with AA genotype (P = 0.001). Alleledependent differential methylation can only be seen in females (P = 0.013). Significant effects are indicated by asterisks (*P ≤ 0.05 and **P ≤ 0.01). Each bar represents mean ± SEM. Fig. 3 . Differences between constructs carrying A allele or G allele at rs886205 SNP in F1 and F6. K562 cells were transfected with pCpGL plasmid containing indicated fragments of the ALDH2 promoter, methylated or unmethylated. Cells were lysed after 24 h; luciferase activity was measured and two-way ANOVA was performed. A significant effect of methylation was observed in F1, F2 and F6 (P < 0.0001). PCpGL-F1_G showed higher luciferase activity than pCpGL-F1_A (P = 0.0220). No genotype by methylation interaction was observed in the pCpGL-F1 fragment. PCpGL-F6_A had significantly higher luciferase activity than PCpGL-F6_G (P = 0.0024). Also, F6 showed a genotype by methylation interaction with genotype losing the effect in the methylated constructs (P = 0.0330). Firefly luciferase activity was normalized to Renilla luciferase activity. Significant effects are indicated by asterisks (*P ≤ 0.05 and **P ≤ 0.01). Each bar represents mean ± SEM.
respective CpGs into two parts: cluster 1 consisting of 6 and cluster 2 of 25 CpGs. Cluster 2 was barely methylated, probably due to its proximity to the core promoter, whereas cluster 1, encompassing NRRE and SNP, differed significantly indicating alcohol-mediated regulation.
Interestingly, cluster 1 CpGs did not show any change in methylation after Day 7 or 14 of alcohol withdrawal, but allele-specific analysis (AA vs. GG and GA), showed a clear difference in the methylation kinetics based on genotype. These results clearly prove that there is a rs886205-genotype-dependent difference in the epigenetic regulation of the analyzed CpGs in the presence of alcohol. The findings corroborate with a previous study from our group where SNP-mediated differences in methylation were observed in alcohol-dependent patients. Since the epigenetic changes associated with rs886205 are present in two distinct regulatory elements of ALDH2 promoter, it is possible that the DNA methylation machinery in different allele types is recruited differentially to the promoter via mechanisms that require further exploration. Having set smoking as a covariate in the linear mixed model, in spite of the difference in distribution between controls and patients, we did not find that smoking had a contributing effect on the data presented.
To investigate if there are gender-restricted changes in the methylation levels of the target sequence, we analyzed the control cohort. Interestingly, we found that females show higher methylation of cluster 1 CpGs at the level comparable to alcohol-intoxicated patients. Furthermore, only A-homozygous females contributed to this difference in methylation. Sex hormones have been implicated in the brain restructuring during puberty and the gender-specific response toward the adverse effects of alcohol consumption (Lenz et al., 2012) . It is known that transcriptional activity of the ALDH2 gene is regulated by binding of RARα/γ and RXRα/γ to a sequence in the promoter. Since the consensus core motif and variants of non-steroid receptors are homologous to estrogen receptor response element (Klinge et al., 1997) , it is likely that estrogen receptor binds to the NRRE in the promoter region, thereby exerting a regulatory role in ALDH2 transcription. It is not clear how these factors recruit the DNA methylation machinery. Replication of the gender-dependent methylation differences in a larger cohort and DNA-protein interaction studies have to be carried out to find if indeed estrogen receptor signaling contributes to these epigenetic changes.
As we already measured testosterone in the patient cohort, we tested if hormone levels correlated with the methylation of analyzed In both fragments F1 and F6 there was a significant effect of methylation (P < 0.0001) and ethanol (P > 0.0001) on luciferase activity. After 48 h of ethanol incubation, a genotype by methylation interaction was observed in F1 (P = 0.003) and F6 (P = 0.007). A significant interaction between ethanol and methylation was observed in both F1 (24 h: P = 0.009 and 48 h: P = 0.001) and F6 (24 h: P < 0.0001 and 48 h: P = 0.05).
CpGs. We found a significant negative association with testosterone levels in acutely intoxicated AA homozygous patients. We observed genotype-dependent differences in the dynamics of this association, as the initial negative association changed into a weak positive association at Day 7 and no association was observed at the end of treatment. G allele carriers showed only a negative association on Day 7. We suppose that these differences are mainly due to the genotypedependent changes in methylation levels and may hint toward a complex interplay between sex hormones and the specific methylation of ALDH2. Alcohol has been shown to convert testosterone to estrogen via the enzyme aromatase (Purohit, 2000) . The negative association of cluster 1 methylation with testosterone indicates the involvement of estrogen. Unfortunately, limited availability of serum samples precluded measurement of estrogen levels in these patients, which we intend to follow up in future studies to assess the clinical significance. Further studies are needed to provide a more detailed insight into the mechanisms behind the observed association.
For in vivo methylation analysis, DNA was extracted from whole blood of patients and controls, therefore we used the lymphoblastoid cell line K562 for in vitro experiments to study the mechanistic significance of methylation on ALDH2 expression.
Luciferase assays demonstrate that pCpGL-F1_G shows higher transcriptional activity in comparison to pCpGL-F1_A while we observed the opposite effect in the complete fragment, pCpGL-F6. This finding is in accordance with the previous studies reporting differential transcriptional activity of ALDH2 promoter cloned with either A or G at SNP rs886205 (Chou et al., 1999; Kimura et al., 2009) . Although methylation significantly reduced the transcriptional activity in both fragments, the interaction between methylation and genotype could be observed only in the complete fragment. This suggests that positive and negative regulatory fragments interact to induce the genotype-mediated epigenetic changes leading to differential transcriptional activity, thereby supporting the in vivo patient data.
As expected, ethanol increased the ALDH2 promoter transcriptional activity significantly even at the lowest concentration (0.05%) proving that the in vitro system is robust. Upon alcohol incubation, there was no significant difference between the transcription of pCpGL-F1/6_A and pCpGL-F1/6_G neither at physiological concentrations of ethanol (0.05% and 0.1%) nor higher concentrations (0.25%, 0.5% and 1%). Alcohol seems to counteract the effect of rs886205 on the transcriptional activity of ALDH2 promoter fragments (F1 and F6), implying that both alcohol and SNP-dependent regulation of ALDH2 share common pathways. The interaction between genotype and methylation as factors suggests that there is a constant difference in the luciferase activity of A and G allele fragments depending on the methylation status. Similarly, the interaction between methylation and ethanol indicates that alcohol-mediated increase in promoter activity differs between methylated and unmethylated plasmids.
As most of the alcohol is metabolized in the liver, it is of great interest to repeat these experiments in a hepatic cell line. Another limitation of our system is the short-term incubation of cells with ethanol compared to the long-term chronic consumption in alcoholdependent patients. Furthermore, the cloned region of ALDH2 promoter might lack the upstream enhancer elements needed for the binding of various regulatory factors.
This study highlights the complexity of various regulatory factors and shows their contribution in ALDH2 regulation. The interaction between allele-dependent methylation and testosterone levels in the alcohol-dependent patients is of critical significance as it opens multiple avenues for novel research on rs886205 mediated regulation of ALDH2. Additionally, it indicates the possible mechanisms through which various SNPs can influence gene regulation.
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